The Leading eBooks Store Online
for Kindle Fire, Apple, Android, Nook, Kobo, PC, Mac, Sony Reader...
Most popular at the top
Tyrosine Kinase Inhibitors for Gastrointestinal Stromal Tumor
Future Medicine Ltd 2012; US$ 136.00Advances in the Treatment of B-Cell Chronic Lymphocytic Leukemia
Future Medicine Ltd 2012; US$ 184.00The past two decades have seen substantial advances in the understanding of chronic lymphocytic leukemia (CLL), including new insights from genetics and molecular biology regarding the heterogeneity in clinical behavior observed in this disease. The Editors highlight how vast and complex the CLL has become, but foresee a new dawn for physicians and... more...
mTOR Inhibitors in Cancer Treatment
Future Medicine Ltd 2011; US$ 136.00Increased understanding of the mTOR signaling pathway in relation to malignant cells has prompted extensive efforts to develop new therapeutic approaches. The six chapters of this book summarize the current status of efforts using mTOR inhibitors for the treatment of several malignancies. First generation mTOR inhibitors (rapalogues) are now approved... more...
Emerging Therapeutics for Melanoma
Future Medicine Ltd 2012; US$ 160.00Understanding of the biology of melanoma has increased substantially during the past two decades, with consequent advances in therapeutic approaches and overall disease management. This book addresses diagnosis, prevention, prognosis, treatment and follow up in melanoma. In twelve chapters from international experts, the book provides a comprehensive... more...
Advances in Personalized Cancer Management
Future Medicine Ltd 2011; US$ 136.00Personalized medicine represents the major hope and, perhaps, the most rational way, to improve health. This book includes six chapters from international expert authors covering the latest advances, challenges and perspectives in addressing current unanswered questions in achieving personalized care. Emphasis is given to the first successful steps... more...
EGFR Inhibitors in Cancer Treatment
Future Medicine Ltd 2012; US$ 136.00Epidermal growth factor receptor (EGFR) is a cell membrane receptor with tyrosine kinase activity that plays a crucial role in the control of key cellular transduction pathways in both normal and cancer cells. EGFR is over-expressed in a variety of human tumors, including head and neck, breast, lung and colorectal cancers thus, it represents... more...
Advances in Pancreatic Cancer Treatment
Future Medicine Ltd 2011; US$ 96.00Pancreatic cancer is a major health issue, with an estimated 43,140 new cases and 36,800 deaths in the USA in 2010, making it the 10th most common cancer diagnosis and the 4th most common cause of cancer-related deaths. Prognosis is poor, with a 5-year survival of less than 5% for all stages. The emphasis of this book is on diagnostics and therapy... more...
Advances in Personalized Therapy for Lung Cancer
Future Medicine Ltd 2011; US$ 96.00Lung cancer is the leading cause of cancer mortality worldwide and presents major challenges for treatment. Unfortunately, most patients are diagnosed with locally advanced or metastatic disease, in spite of great efforts toward early detection. Most anticancer drugs that have been introduced recently to the clinic are molecular target-based drugs,... more...
Emerging Applications of Colloidal Noble Metals in Cancer Nanomedicine
Future Medicine Ltd 2012; US$ 96.00Analgesics for Cancer Pain
Future Medicine Ltd 2012; US$ 136.00Although current pain management techniques are efficacious in many patients, there remain many patients in whom pain is inadequately controlled. This eight-chapter work from internationally recognized experts provides a thorough overview of this challenging and topical issue. The books first chapter examines the complexity of clinical cancer... more...









